JPWO2020041876A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020041876A5 JPWO2020041876A5 JP2021536116A JP2021536116A JPWO2020041876A5 JP WO2020041876 A5 JPWO2020041876 A5 JP WO2020041876A5 JP 2021536116 A JP2021536116 A JP 2021536116A JP 2021536116 A JP2021536116 A JP 2021536116A JP WO2020041876 A5 JPWO2020041876 A5 JP WO2020041876A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- sequence
- tumor antigen
- normal
- map
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024053328A JP2024112795A (ja) | 2018-08-30 | 2024-03-28 | 腫瘍特異的抗原を特定するためのプロテオゲノミクスに基づいた方法 |
| JP2025080187A JP2025122019A (ja) | 2018-08-30 | 2025-05-13 | 腫瘍特異的抗原を特定するためのプロテオゲノミクスに基づいた方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724760P | 2018-08-30 | 2018-08-30 | |
| US62/724,760 | 2018-08-30 | ||
| PCT/CA2019/051186 WO2020041876A1 (en) | 2018-08-30 | 2019-08-28 | Proteogenomic-based method for identifying tumor-specific antigens |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024053328A Division JP2024112795A (ja) | 2018-08-30 | 2024-03-28 | 腫瘍特異的抗原を特定するためのプロテオゲノミクスに基づいた方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021534830A JP2021534830A (ja) | 2021-12-16 |
| JPWO2020041876A5 true JPWO2020041876A5 (https=) | 2022-08-31 |
| JP2021534830A5 JP2021534830A5 (https=) | 2022-08-31 |
| JP7468911B2 JP7468911B2 (ja) | 2024-04-16 |
Family
ID=69643063
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536116A Active JP7468911B2 (ja) | 2018-08-30 | 2019-08-28 | 腫瘍特異的抗原を特定するためのプロテオゲノミクスに基づいた方法 |
| JP2024053328A Pending JP2024112795A (ja) | 2018-08-30 | 2024-03-28 | 腫瘍特異的抗原を特定するためのプロテオゲノミクスに基づいた方法 |
| JP2025080187A Pending JP2025122019A (ja) | 2018-08-30 | 2025-05-13 | 腫瘍特異的抗原を特定するためのプロテオゲノミクスに基づいた方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024053328A Pending JP2024112795A (ja) | 2018-08-30 | 2024-03-28 | 腫瘍特異的抗原を特定するためのプロテオゲノミクスに基づいた方法 |
| JP2025080187A Pending JP2025122019A (ja) | 2018-08-30 | 2025-05-13 | 腫瘍特異的抗原を特定するためのプロテオゲノミクスに基づいた方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11702450B2 (https=) |
| EP (1) | EP3844172A4 (https=) |
| JP (3) | JP7468911B2 (https=) |
| KR (1) | KR102944795B1 (https=) |
| CN (2) | CN112639136B (https=) |
| AU (1) | AU2019330487B2 (https=) |
| BR (1) | BR112021002394A2 (https=) |
| CA (1) | CA3109716A1 (https=) |
| IL (1) | IL280651B2 (https=) |
| MX (1) | MX2021002333A (https=) |
| SG (1) | SG11202100528YA (https=) |
| WO (1) | WO2020041876A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111477274B (zh) * | 2020-04-02 | 2020-11-24 | 上海之江生物科技股份有限公司 | 微生物目标片段中特异性区域的识别方法、装置及应用 |
| US20230158132A1 (en) * | 2020-04-14 | 2023-05-25 | Universite De Montreal | Novel tumor-specific antigens for acute lymphoblastic leukemia (all) and uses thereof |
| AU2021256477A1 (en) * | 2020-04-14 | 2022-11-10 | Université de Montréal | Novel tumor-specific antigens for acute myeloid leukemia (AML) and uses thereof |
| JP2023540904A (ja) | 2020-08-25 | 2023-09-27 | シアー， インコーポレイテッド | タンパク質および核酸をアッセイするための組成物および方法 |
| CN112331267A (zh) * | 2020-09-25 | 2021-02-05 | 浙江大学 | 一种基于质谱的不动杆菌数据库的构建方法及不动杆菌数据库 |
| US20240382590A1 (en) * | 2021-07-16 | 2024-11-21 | Université de Montréal | Novel tumor-specific antigens for cancer stem cells and uses thereof |
| CN113593649B (zh) * | 2021-08-02 | 2022-09-09 | 中国人民解放军陆军军医大学第一附属医院 | 一种利用hla-i候选肽库鉴定组织中提取的天然抗原肽的方法 |
| KR102694155B1 (ko) * | 2021-09-14 | 2024-08-13 | 한국과학기술원 | 막 단백질 정보를 이용한 치료 타깃 유전자 발굴 방법 및 분석장치 |
| MX2024003142A (es) * | 2021-09-17 | 2024-04-10 | Univ Montreal | Antigenos especificos de tumores novedosos para el cancer colorrectal y usos de estos. |
| US20260048105A1 (en) * | 2022-08-08 | 2026-02-19 | Université de Montréal | Novel antigens for cancer and uses thereof |
| AU2024287610A1 (en) * | 2023-07-12 | 2026-01-29 | Anda Biology Medicine Development (Shenzhen) Co., Ltd | Novel markers for tumor neoantigen vaccines |
| JP7599641B1 (ja) | 2023-08-22 | 2024-12-16 | ｃＢｉｏｉｎｆｏｒｍａｔｉｃｓ株式会社 | ネオアンチゲン予測装置、ネオアンチゲン予測方法、およびプログラム |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1020519A1 (en) | 1999-01-15 | 2000-07-19 | Introgene B.V. | Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| JP2006129832A (ja) * | 2004-11-09 | 2006-05-25 | Aichi Prefecture | ＣａｔｈｅｐｓｉｎＨタンパク質由来のＣＤ８＋細胞傷害性Ｔリンパ球ｍＨＡエピトープペプチド及びその用途 |
| EP1748067A1 (en) * | 2005-07-29 | 2007-01-31 | Institut Pasteur | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
| WO2007119515A1 (ja) * | 2006-03-28 | 2007-10-25 | Dainippon Sumitomo Pharma Co., Ltd. | 新規腫瘍抗原ペプチド |
| CN102268089A (zh) | 2011-07-05 | 2011-12-07 | 上海交通大学 | Agr2阻断抗体及其用途 |
| CA2988388C (en) * | 2015-04-23 | 2022-11-22 | Nantomics, Llc | Cancer neoepitopes |
| GB201511191D0 (en) * | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
| RU2729116C2 (ru) * | 2015-12-16 | 2020-08-04 | Гритстоун Онколоджи, Инк. | Идентификация, производство и применение неоантигенов |
| CN109416925A (zh) * | 2016-05-05 | 2019-03-01 | 南托米克斯有限责任公司 | 检查点失效和使检查点失效的方法 |
| US10350280B2 (en) * | 2016-08-31 | 2019-07-16 | Medgenome Inc. | Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore |
| PE20191345A1 (es) * | 2016-11-23 | 2019-09-30 | Gritstone Oncology Inc | Administracion viral de neoantigenos |
| JP7197481B2 (ja) * | 2016-11-30 | 2022-12-27 | アドバクシス， インコーポレイテッド | 反復性がん突然変異を標的とする免疫原性組成物およびその使用の方法 |
| CN118666956A (zh) | 2019-06-25 | 2024-09-20 | 蒙特利尔大学 | 肿瘤抗原肽、肽组合、核酸、负载体、疫苗及其用途 |
-
2019
- 2019-08-28 IL IL280651A patent/IL280651B2/en unknown
- 2019-08-28 SG SG11202100528YA patent/SG11202100528YA/en unknown
- 2019-08-28 BR BR112021002394-1A patent/BR112021002394A2/pt unknown
- 2019-08-28 CA CA3109716A patent/CA3109716A1/en active Pending
- 2019-08-28 KR KR1020217008983A patent/KR102944795B1/ko active Active
- 2019-08-28 CN CN201980056943.7A patent/CN112639136B/zh active Active
- 2019-08-28 WO PCT/CA2019/051186 patent/WO2020041876A1/en not_active Ceased
- 2019-08-28 US US17/267,914 patent/US11702450B2/en active Active
- 2019-08-28 JP JP2021536116A patent/JP7468911B2/ja active Active
- 2019-08-28 EP EP19853634.4A patent/EP3844172A4/en active Pending
- 2019-08-28 MX MX2021002333A patent/MX2021002333A/es unknown
- 2019-08-28 AU AU2019330487A patent/AU2019330487B2/en active Active
- 2019-08-28 CN CN202410944143.1A patent/CN118755835A/zh active Pending
-
2023
- 2023-02-15 US US18/169,870 patent/US20230242583A1/en active Pending
-
2024
- 2024-03-28 JP JP2024053328A patent/JP2024112795A/ja active Pending
-
2025
- 2025-05-13 JP JP2025080187A patent/JP2025122019A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534830A5 (https=) | ||
| JP7592060B2 (ja) | 免疫原性変異体ペプチドスクリーニングプラットフォーム | |
| CN112639136B (zh) | 用于鉴定肿瘤特异性抗原的基于蛋白质基因组学的方法 | |
| CN104662171B (zh) | 个性化癌症疫苗和过继免疫细胞治疗 | |
| AU2007259667B2 (en) | SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same | |
| JP2019510465A (ja) | 乳がんおよびその他のがんに対する免疫療法において使用するためのペプチドおよびペプチドの組み合わせ | |
| JPWO2020041876A5 (https=) | ||
| JP2007527225A (ja) | Ｅｐｈａ２ｔ−細胞エピトープアゴニストおよびその使用 | |
| WO2025097243A1 (en) | Colorectal tumor antigens and uses thereof | |
| US20190359681A1 (en) | Novel minor histocompatibility antigens and uses thereof | |
| HK1242779B (zh) | 免疫原性突变体肽筛选平台 | |
| HK1242779A1 (en) | Immunogenic mutant peptide screening platform | |
| Weinschenk | Multi-peptide based vaccines for personalized cancer therapy: analytical fundamentals translated into clinical applications |